LEIDOS BIOMEDICAL RESEARCH, INC.
PROTEOMIC AND ANTIBODY PRODUCTION AND CHARACTERIZATION
PROTEOMIC AND ANTIBODY PRODUCTION AND CHARACTERIZATION is a funding opportunity from LEIDOS BIOMEDICAL RESEARCH, INC., up to 10719410, closing August 31, 2029.
Aug 31, 2029
(1127d left)Overview
The ACL will produce and characterize fit-for-purpose affinity reagents based on the individual requestor’s specifications. These reagents will be produced and characterized using validated methods, ensuring the NIH Rigor and Reproducibility Principles and Guidelines are followed. A key focus of this project will be…